Related Experiment Video
Updated: Aug 19, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
[Binding and inhibition of adeno-associated virus Rep78 protein with hepatitis B virus C promoter]
Zhong-yu Yan1, Min Cong, Ping Wang
1Liver Disease Research Center, Beijing Friendship Hospital, Capital University of Medical Sciences, Beijing 100050, China.
Objectives:
Adeno-associated virus (AAV) Rep78 is known for its inhibitory effects on replication of several viruses and oncogenes transformations. The study was to investigate the effect of Rep78 on hepatitis B virus C (HBV-C) gene and the mechanism of it.
Methods:
HBV-C promoter and HBV-C gene with its promoter were amplified by PCR and labeled with 32P-ATP. Electrophoretic mobility shift assay (EMSA) and in vitro transcription were utilized to detect the binding of MBP-Rep78 with HBV-C promoter and the transcription of HBV-C gene.
Results:
EMSA showed that by increasing the amount of Rep78 protein from 0.1 microg to 1.0 microg, the binding bands got stronger in a dose-dependent manner. In addition, Rep78 antibody was used to certify the specificity of this binding. The compound of Rep78, Rep78 antibody and HBV-C promoter were seen as super shift bands in EMSA. Meanwhile, HBV-C gene transcription was significantly inhibited by in vitro transcription which meant that Rep78 could not only bind with HBV-C promoter, but also could inhibit the transcription of HBV-C gene.
Conclusion:
AAV Rep78 could inhibit the transcription of HBV-C gene through its binding with HBV-C promoter.
Insights
Adeno-associated virus Rep78 protein inhibits hepatitis B virus C gene transcription. This occurs through direct binding to the hepatitis B virus C promoter, demonstrating a novel antiviral mechanism.
Area of Science:
- Molecular Virology
- Gene Regulation
- Antiviral Mechanisms
Context:
- Hepatitis B virus C (HBV-C) poses a significant global health challenge.
- Adeno-associated virus (AAV) Rep78 protein exhibits known antiviral and anti-oncogenic properties.
- Understanding host-pathogen interactions is crucial for developing novel therapeutic strategies.
Purpose:
- To investigate the inhibitory effect of AAV Rep78 on the HBV-C gene.
- To elucidate the underlying molecular mechanism of Rep78's action on HBV-C.
Summary:
- Electrophoretic mobility shift assays (EMSA) demonstrated a dose-dependent binding of Rep78 to the HBV-C promoter.
- In vitro transcription assays revealed that Rep78 significantly inhibits HBV-C gene transcription.
- Specificity of binding was confirmed using Rep78 antibodies, leading to super shift bands in EMSA.
Impact:
- Identifies AAV Rep78 as a potential inhibitor of HBV-C replication.
- Provides mechanistic insights into how Rep78 modulates viral gene expression.
- Suggests AAV Rep78 as a candidate for future antiviral therapies against HBV-C.
More Related Videos
Related Concept Videos
Inhibitors Of Virion Release
Hepatitis
Inhibitors of Virion Maturation and Assembly
Inhibitors of Viral Protein Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Viruses with RNA Genomes

